Model-based Development of Anacetrapib, a Novel Cholesteryl Ester Transfer Protein Inhibitor Publication Model-based Development of Anacetrapib, a Novel Cholesteryl Ester Transfer Protein Inhibitor A model-based strategy was used to inform the early clinical development of anacetrapib, a novel…CertaraJune 1, 2011
Pharmacokinetics of Clofarabine in Patients with High-risk Inherited Metabolic Disorders Undergoing Brain-sparing Hematopoietic Cell Transplantation Publication Pharmacokinetics of Clofarabine in Patients with High-risk Inherited Metabolic Disorders Undergoing Brain-sparing Hematopoietic Cell Transplantation Clofarabine, a newer purine analog with reduced central nervous system toxicity, may prove advantageous in…CertaraMay 1, 2011
Systematic Review: Diagnostic Accuracy of Clinical Decision Rules for Venous Thromboembolism in Elderly Publication Systematic Review: Diagnostic Accuracy of Clinical Decision Rules for Venous Thromboembolism in Elderly Physicians committed to the care of elderly patients are challenged with the diagnosis of venous…CertaraApril 1, 2011
Resurgence in the Use of Physiologically-based Pharmacokinetic Models in Pediatric Clinical Pharmacology: Parallel Shift in Incorporating the Knowledge of Biological Elements and Increased Applicability to Drug Development and Clinical Practice Publication Resurgence in the Use of Physiologically-based Pharmacokinetic Models in Pediatric Clinical Pharmacology: Parallel Shift in Incorporating the Knowledge of Biological Elements and Increased Applicability to Drug Development and Clinical Practice This study had two primary aims: (i) To describe an example of the development work…CertaraMarch 1, 2011
Meta-analysis of Thoracic Epidural Anesthesia Versus General Anesthesia for Cardiac Surgery Publication Meta-analysis of Thoracic Epidural Anesthesia Versus General Anesthesia for Cardiac Surgery A combination of general anesthesia (GA) with thoracic epidural anesthesia (TEA) may have a beneficial…CertaraFebruary 1, 2011
The Role of the Breast Cancer Resistance Protein (ABCG2) in the Distribution of Sorafenib to the Brain Publication The Role of the Breast Cancer Resistance Protein (ABCG2) in the Distribution of Sorafenib to the Brain ATP-binding cassette transporters P-glycoprotein (P-gp) and breast cancer resistance protein (BCRP) have been shown to…CertaraJanuary 1, 2011
Modeling Disease Progression in Acute Stroke Using Clinical Assessment Scales Publication Modeling Disease Progression in Acute Stroke Using Clinical Assessment Scales This article demonstrates techniques for describing and predicting disease progression in acute stroke by modeling…CertaraDecember 1, 2010
Development of a Modeling Framework to Simulate Efficacy Endpoints for Motesanib in Thyroid Cancer Patients Publication Development of a Modeling Framework to Simulate Efficacy Endpoints for Motesanib in Thyroid Cancer Patients To develop a modeling framework that simulates clinical endpoints (objective response rate and progression-free survival)…CertaraNovember 1, 2010
Population Pharmacokinetic/Pharmacodynamic Modeling for the Time Course of Tumor Shrinkage by Motesanib in Thyroid Cancer Patients Publication Population Pharmacokinetic/Pharmacodynamic Modeling for the Time Course of Tumor Shrinkage by Motesanib in Thyroid Cancer Patients To develop a population pharmacokinetic/pharmacodynamic model describing the relationship between motesanib exposure and tumor response…CertaraNovember 1, 2010
Randomised, Parallel-group, Multicenter, Multinational Phase 2 Study Comparing Edoxaban, an Oral Factor Xa Inhibitor, with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation Publication Randomised, Parallel-group, Multicenter, Multinational Phase 2 Study Comparing Edoxaban, an Oral Factor Xa Inhibitor, with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation The primary objective of this study was to compare the safety of four fixed-dose regimens…CertaraSeptember 10, 2010